A Study of BRY805 in Participants With Advanced Solid Tumors

NCT06289894 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

13

Enrollment

INDUSTRY

Sponsor class

Stopped Adjustment of the company's R\&D strategy

Conditions

Advanced Solid Tumor

Interventions

DRUG: BRY805 injection

Sponsor

BioRay Pharmaceutical Co., Ltd.